CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CoreRx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10552
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CoreRx Inc (CoreRx) is a contract development manufacturing organization that provides a comprehensive range of drug development services. The company provides products portfolio such as oral, topical, liquids or parental, ophthalmic and combined medicines, among others. It provides a wide range of drug product development services for manufacturing and testing of solid, liquid and semi-solid dosage forms, among others. CoreRx provides services such as formulation development, analytical and clinical material manufacturing solutions. It provides topical products in various dosage forms including gels, creams, ointments, lotions, capsules, tablets, thin film strips, suspensions, injectables, and others. The company caters pharmaceutical and biotechnology industries. CoreRx is headquartered in Clearwater, Florida, the US.

CoreRx Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CoreRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CoreRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CoreRx Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CoreRx Raises USD5 Million in Venture Financing 10
CoreRx Raises USD7 Million in Venture Financing 11
Partnerships 12
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 12
Equity Offering 13
CoreRx Raises Funds in Private Placement of Shares 13
CoreRx Inc – Key Competitors 14
CoreRx Inc – Key Employees 15
CoreRx Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
Jun 07, 2017: CoreRx and Aimmune Therapeutics Joint Expansion to Create Pharmaceutical Jobs and Increase the Base of Scientific Capabilities in the Tampa Bay Area 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CoreRx Inc, Pharmaceuticals & Healthcare, Key Facts 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CoreRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CoreRx Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CoreRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CoreRx Raises USD5 Million in Venture Financing 10
CoreRx Raises USD7 Million in Venture Financing 11
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 12
CoreRx Raises Funds in Private Placement of Shares 13
CoreRx Inc, Key Competitors 14
CoreRx Inc, Key Employees 15

List of Figures
CoreRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CoreRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hayleys PLC (HAYL.N0000):企業の財務・戦略的SWOT分析
    Summary Hayleys plc (Hayleys) is a diversified company that offers consumer services. The company’s products include purification products, textiles and construction materials, among others. It offers services such as treasury unit, strategic business development unit, corporate communications, corp …
  • Dova Pharmaceuticals Inc (DOVA)-製薬・医療分野:企業M&A・提携分析
    Summary Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia …
  • Addnode Group AB (ANOD B):企業の財務・戦略的SWOT分析
    Summary Addnode Group AB (Addnode) is an information technology company that supplies software and services for construction, design, and product data information. The company's solutions include design management solutions, process management solutions, and product lifecycle management solutions, a …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • Salt River Project:企業の戦略・SWOT・財務分析
    Salt River Project - Strategy, SWOT and Corporate Finance Report Summary Salt River Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Oberbank AG:企業の戦略・SWOT・財務分析
    Oberbank AG - Strategy, SWOT and Corporate Finance Report Summary Oberbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Maintel Holdings Plc (MAI):企業の財務・戦略的SWOT分析
    Summary Maintel Holdings Plc (Maintel) is a telecommunication service provider that supports voice and data equipments. The company provides collaborations, customer experience and optimization, connectivity, security and networking, mobile professional and transformation services and managed servic …
  • GSE Group:企業の戦略・SWOT・財務情報
    GSE Group - Strategy, SWOT and Corporate Finance Report Summary GSE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • WH Ireland Group Plc (WHI):企業の財務・戦略的SWOT分析
    WH Ireland Group Plc (WHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報
    Summary Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutic …
  • Newfoundland and Labrador Hydro:企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Perdue Farms Inc.:企業の戦略・SWOT・財務分析
    Perdue Farms Inc. - Strategy, SWOT and Corporate Finance Report Summary Perdue Farms Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Invacare Corporation (IVC)-医療機器分野:企業M&A・提携分析
    Summary Invacare Corporation (Invacare) is a medical equipment company which develops, manufactures and distributes healthcare products for non-acute care, such as the home healthcare and long term care markets. The major products include power wheelchairs, custom manual wheelchairs, personal mobili …
  • Cargill, Incorporated:企業のM&A・事業提携・投資動向
    Cargill, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cargill, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Special Metals Corp:企業の戦略・SWOT・財務分析
    Special Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Special Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • FirstEnergy Corp:企業の発電所・SWOT分析2018
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Tenaga Nasional Berhad:戦略・SWOT・企業財務分析
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Essilor International S.A.:企業の戦略・SWOT・財務情報
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆